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Aims: Atherosclerosis is an inﬂammatory process with different cardiovascular risk factors
(CVRFs) contributing to its pathogenesis. We aimed to evaluate the speciﬁc relationship
between circulating blood leukocytes, troponin I and CVRFs.
Methods: We prospectively enrolled 959 patients with evidence of acute coronary syndrome
either in form of unstable angina or STEMI or NSTEMI. Details demographic characteristics,
CVRF and biochemical parameters such as total white blood cells (WBC), neutrophil,
lymphocytes, platelet, neutrophil/lymphocyte ratio (NLR), platelet/lymphocyte ratio (PLR),
and troponin I were collected.
Results: The results indicated that patients having either hypertension, diabetes or smok-
ing habit had signiﬁcantly higher levels of totalWBC ( p = 0.013), neutrophil ( p = 0.029), NLR
( p = 0.029) and PLR ( p = 0.009). The level of troponin I was unaffected by these risk factors.
Signiﬁcant association of hypertension was found with total WBC ( p = 0.0392), lympho-
cytes ( p = 0.0384) and PLR ( p = 0.0027), whereas in diabetes and females all other leukocyte
subtypes were signiﬁcantly altered except for platelet and troponin I. Smokers had higher
level of total WBC count ( p = 0.0033) and PLR ( p = 0.0464). No relationship between CVRFs
and leukocytes was observed inmales. The age independent effect was observed with PLR,
whereas association with total WBC, lymphocytes, NLR, platelet was speciﬁc in older
er patients NLR ( p = 0.0453) is more likely to be elevated. Mortality
sociated with changes in the leukocytes but not with the CVRFwas signiﬁcantly as
presence.population. In young* Corresponding author at: Department of Cardiology, U. N. Mehta Institute of Cardiology and Research Centre, Civil Hospital Campus,
Ahmedabad 380016, Gujarat, India. Tel.: +91 9426020154; fax: +91 079 22682092.
E-mail address: kamalsharma1975@gmail.com (K.H. Sharma).
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Conclusion: We demonstrate that the neutrophils, lymphocytes and total WBC along with its
ratios predict mortality and are more likely to be elevated in presence of CVRFs.
# 2015 Cardiological Society of India. Published by Elsevier B.V. All rights reserved.
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diseases (CVD) is the challenge imposed to South Asians
especially Indians due to urbanization, epidemic transition
and genetic susceptibility.1,2 South Asian ethnicity itself is
considered as one of the risk factor of CVD and the prevalence
of various cardiovascular risk factors (CVRFs) predisposes this
population to premature vascular ageing.3
Atherosclerosis, formerly known as a disease of lipid
storage is actually a complex cardiac condition involving
active and chronic inﬂammatory process. Hypertension,
diabetes, addiction, age, gender and hereditary factors all
contribute to the progression of atherosclerosis; however
inﬂammatory cells also play a vital role in this process.4–6 In
various animal and human model of atherosclerosis, circulat-
ing blood components like neutrophil, lymphocyte, platelets,
and other inﬂammatory mediators were found in the lesions.7
Pathophysiology of atherosclerosis involves chemotactic
proteins and adhesion molecules mediated recruitment of
circulating leucocytes and platelets to the injured endotheli-
um site.8 Damage to the endothelium upsets the balance
between vasoconstriction and vasodilation that promotes the
endothelial permeability, platelet aggregation, leukocyte
adhesion, and generation of cytokines ultimately initiating
deleterious events of atherosclerosis.9
All leukocyte subtype are known to contribute in the
development of atherosclerotic plaque and hence the presence
of elevated neutrophils, platelets and low lymphocyte are
associated with a risk of coronary artery disease (CAD) and are
shown to be the predictor of mortality.10 Several studies have
documented a link between an elevated leukocyte count to
increased short- and longer-term risk for ischemic events and
death in patients presenting with acute coronary syndromes
(ACS).11 Despite this strong association of circulating inﬂam-
matory markers with cardiovascular risk, the connection of
these markers with conventional risk factors of CVD is highly
unexplored.
The current study was undertaken to investigate the
speciﬁc relationship of circulating blood components with
classical andmodiﬁable CVRFs such as hypertension, diabetes
and smoking in ACS patients with prognostic value for this
simple assessment.2. Methods
This prospective and observational studywas conducted at U.
N. Mehta Institute of cardiology and research centre and was
approved by institutional ethics committee (UNMICRC/
CARDIO/13/43). All clinical investigations were conductedaccording to the principles expressed in the Declaration of
Helsinki.
2.1. Study subjects
All comer adults presenting with acute coronary syndrome
(ACS) diagnosed based on ACC/AHA deﬁnition were included
as study subjects. Total 959 individuals of both the genders
(635males& 324 females)were enrolled for study from January
to December 2013. Any patient with evidence of infection like
sepsis, fever were excluded from the study. All patients were
also evaluated for Chest X-ray and urine routine and
microscopic examination along with to exclude any abnor-
malities.
2.2. Clinical variables and cardiovascular risk factors
Baseline characteristics were recorded during the direct
interview with the patient. Hypertension was deﬁned as
the active use of antihypertensive drugs or documentation of
blood pressure more than 140/90 mmHg, and diabetes
mellitus was deﬁned as fasting plasma glucose (FPG) levels
over 126 mg/dl or glucose level over 200 mg/dl at any
measurement or active use anti-diabetic treatment. Smoking
was deﬁned as current smoking status of an individual.
Complete blood count andbiochemical valueswere evaluated
from blood samples obtained by antecubital vein puncture.
Demographic properties included age and gender, and
biochemical parameters included complete blood count
and quantitative troponin I. Traditional CVRFs were deﬁned
as presence of hypertension, diabetes mellitus and current
smoking status.
2.3. Laboratory analysis
Blood sample for laboratory assessment were collected upon
ﬁrst point of patient contact to refrain from bias. Total
leucocyte count and its subtypes including neutrophil,
lymphocyte and platelet count were analysed using an
automated blood cell counter. Troponin I and leukocyte were
sent from the same sample to evaluate temporal correlation.
2.4. Statistical methods
All statistical studies were carried out using SPSS program vs
20. Neutrophil/lymphocyte (NLR) ratio and platelet/lympho-
cyte (PLR)were automatically calculated by loading all the data
to the statistical program used. Quantitative variables were
expressed as the mean  standard deviation and qualitative
variables were expressed as percentage (%). A comparison of
parametric values between two groups was performed using
the independent sample t test. Categorical variables were
i n d i a n h e a r t j o u r n a l 6 7 ( 2 0 1 5 ) 4 4 4 – 4 5 1446compared using the chi-square test. A nominal signiﬁcance
was taken as a two tailed p value<0.05.3. Results
3.1. Demographic details, cardiovascular risk factors and
inﬂammatory cells
The demographic details of the patients are presented in
Table 1. There were 959 patients having an overall mean age of
57.36 12.48 years. The study cohort was further grouped into
the patients with and without the presence of CVRFs. The
comparison of the circulating leukocytes from both the groups
indicated that patients having either hypertension, diabetes or
smoking habit had signiﬁcantly higher levels of total WBC
counts (p = 0.013),neutrophil (p = 0.029),NLR (p = 0.029)andPLR
(p = 0.009). Whereas the level of lymphocyte was signiﬁcantlyTable 1 – Demographic characteristics of the population.
Variables Total (n = 959) Patient hav
factor (n
Gender Male- 635 (66.21)
Female- 324 (33.78)
Male- 151 (6
Female- 88 (
Age 57.36  12.48 56.32  13.68
Total WBC
Mean  SD 11395.36  7393.9 10365.48  3
Quartiles 25 8473 8330
50 10340 9856
75 13300 11500
Neutrophil
Mean  SD 71.74  10.267 70.48  10.67
Quartiles 25 65 63
50 73 72
75 80 79
Lymphocyte
Mean  SD 22.59  13.81 24.78  22.77
Quartiles 25 15 16
50 20 21
75 28 29
NLR
Mean  SD 4  2.115 3.74  2.02
Quartiles 25 2.33 2.16
50 3.60 3.27
75 5.33 4.93
Platelet
Mean  SD 284244.54  111792.2 280599.37 
Quartiles 25 211000 212000
50 271000 262000
75 346000 344700
PLR
Mean  SD 0.15  0.087 0.13  0.06
Quartiles 25 0.09 0.09
50 0.13 0.12
75 0.19 0.17
Troponin I
Mean  SD 6.32  13.97 5.94  14.01
Quartiles 25 0.02 0.01
50 0.14 0.06
75 2.94 2.35
Mortality 96 (10.01) 26 (10.88)
WBC: white blood cell, NLR: neutrophil lymphocyte ratio, PLR: platelet lylower (p = 0.05) in patients having any of the risk factors as
compared to the patients having no risk factor. The level of
troponin I (p = 0.679) and mortality (p = 0.695) were unaffected
by the presence of risk factors. The quartiles (25, 50 and 75) for
various inﬂammatory markers were also found to vary in
presence of CVRF.
3.2. Association between cardiovascular risk factors,
cardiac troponin I and inﬂammatory markers
The inﬂuence of individual CVRF on blood cells and troponin I
is tabulated in Table 2. Effect of hypertension, diabetes,
smoking and ageing wasmost profound and common on total
WBC count. The mean WBC count (12020.14  8019.74) of the
smokerswere highest followed by diabetic (11745.53  9881.11)
and hypertensive (11652.50  9173.54) patients. However in
comparison to patients having no CVRFs, neutrophil counts
were signiﬁcantly (p = 0.0101) elevated (72.81  9.79 vs 70.48ing no risk
= 239)
Patient having risk
factor (n = 720)
P value
3.18)
36.8)
Male- 484 (67.22)
Female- 236 (32.77)
–
57.7  12.05 0.139
523.21 11737.22  8262.22 0.013
8507
10600
13800
72.16  10.10 0.029
65
74
80
21.86  8.96 0.05
15
20
27
4.09  2.13 0.029
2.40
3.65
5.33
104688.36 285454.52  114096.61 0.561
211000
274000
346075
0.15  0.09 0.009
0.02
0.16
3.46
6.37  13.91 0.679
0.02
0.16
3.46
70 (9.72) <0.001
mphocyte ratio, SD: standard deviation.
Table 2 – Association between specific CVRFs, cardiac troponin I and inflammatory markers.
Variables Patient having no
risk factor (n = 239)
Hypertension
(n = 351)
P- value Diabetes
(n = 285)
P- value Smoker
(n = 282)
P- value
Total WBC
Mean  SD 10365.48  3523.21 11652.50  9173.54 0.039 11745.53  9881.11 0.041 12020.14  8019.74 0.003
Quartiles 25 8330 8300 8374 8673
50 9856 10400 10400 10800
75 11500 13600 13800 14005
Neutrophil
Mean  SD 70.48  10.67 71.96  10.11 0.088 2.81  9.97 0.010 72.24  10.30 0.057
Quartiles 25 63 65 67 65
50 72 74 74 74
75 79 80 80 80
Lymphocyte
Mean  SD 24.78  22.77 21.98  9.07 0.038 21.49  8.76 0.025 21.96  9.21 0.057
Quartiles 25 16 15 15 15
50 21 20 20 20
75 29 27 27 27
NLR
Mean  SD 3.74  2.02 4.04  2.06 0.081 4.15  2.10 0.024 4.11  2.18 0.046
Quartiles 25 2.17 2.32 2.52 2.36
50 3.27 3.7 3.70 3.70
75 4.94 5.33 5.33 5.35
Platelet
Mean  SD 280599.4  104688.4 284854.01  116778.8 0.651 291689.2  123047.9 0.272 278164.8  106152.9 0.793
Quartiles 25 212000 209000 211000 208000
50 262000 275400 271000 264000
75 344700 346100 358050 338950
PLR
Mean  SD 0.13  0.06 0.15  0.09 0.003 0.16  0.09 <0.0001 0.15  0.09 0.004
Quartiles 25 0.09 0.09 0.09 0.09
50 0.12 0.13 0.13 0.13
75 0.18 0.20 0.21 0.20
Troponin I
Mean  SD 5.94  14 4.96  12.16 0.367 5.72  13.5 0.855 8.40  15.6 0.061
Quartiles 25 0.01 0.01 0.02 0.03
50 0.06 0.12 0.17 0.30
75 2.346 2.080 2.354 6.682
Mortality 26 (10.88%) 40 (11.4%) 0.950 36 (12.63%) 0.639 22 (7.8%) 0.290
WBC: white blood cell, NLR: neutrophil lymphocyte ratio, PLR: platelet lymphocyte ratio, SD: standard deviation.
i n d i a n h e a r t j o u rn a l 6 7 ( 2 0 1 5 ) 4 4 4 – 4 5 1 447 10.67) in diabetics only. The mean lymphocyte count in
patients suffering from hypertension or diabetes were 21.98
 9.07 and 21.49  8.76 respectively, which was signiﬁcantly
(p = 0.038 & p = 0.025) lower as compared to patients having no
risk factors (24.78  22.77). In case of NLR, elevation was
observed in diabetics (4.15  2.10 vs 3.74  2.02) and smokers
(4.11  2.18 vs 3.74  2.02), which could not reach to a
statistically signiﬁcant level in hypertensive population
(p = 0.081). The PLR was highly inﬂuenced by high blood
pressure (0.15  0.09; p = 0.003), sugar levels (0.16  0.09;
p < 0.0001) and smoking (0.15  0.009; p = 0.004) whereas the
levels of troponinwere unaltered by any of the CVRF. Mortality
incidence were comparable in all four groups.
3.3. The impact of gender and age on cardiovascular risk
factors, cardiac troponin I and inﬂammatory cells
Incidences of hypertension (46.6% vs 34.56%) and diabetes
(34.56% vs 27.2%) were higher in females as compared to
males, however the habit of smoking was more prevalent in
males (13.9% vs 37.3%). The relationship of genderwith various
CVRFs were analysed and are shown in Table 3. There was noassociation amongstmaleswherenone of theCVRF in patients
with risk factor was neither signiﬁcantly elevated nor lowered
in comparison to patients having no risk factor. Contrarily, in
females a strong association of total WBC count ( p = 0.023),
neutrophil ( p = 0.0005), lymphocyte (p = 0.001), NLR (p = 0.001)
and PLR ( p = 0.007) with CVRFs was observed. Age-induced
changes in the correlation between CVRFs and WBC subtypes
are presented in Table 4. In young (≤40 years), the NLR (4.17
 2.23 vs 3.2940  1.88; p = 0.045) and PLR (0.159  0.077 vs
0.127  0.063; p = 0.032) were inﬂuenced by the presence or
absence of the CVRFs. The population > 40 years of age showed
changes in WBC (11773.38 8560.12 vs 10361.67 3620.72;
p = 0.023), lymphocyte (21.88 8.94 vs 24.68  24.58; p = 0.014),
platelets (283976.45 113343.38 vs 27187.25 91602.9;
p = 0.032) and PLR (0.1543 0.09 vs 0.139  0.07; p = 0.034) in
presence of various CVRFs.
3.4. Association of various inﬂammatory markers and
cardiac troponin I with mortality
Table 5 shows comparison between inﬂammatory cell types &
marker levels of expired and survived patients. Except for PLR
Table 4 – The impact of age on CVRFs, cardiac troponin I and inflammatory markers.
Variables Age ≤ 40
(with no risk factor)
n = 39
Age ≤ 40
(with risk factor)
n = 60
P value Age > 40
(with no risk factor)
n = 200
Age > 40
(with risk factor)
n = 660
P value
Total WBC 10385.08  3015.23 11339.55  3643.13 0.177 10361.67  3620.72 11773.38  8560.12 0.023
Neutrophil 68.23  10.23 72.32  10.00 0.052 70.93  10.72 72.15  10.12 0.141
Lymphocyte 25.31  9.15 21.73  9.27 0.062 24.68  24.58 21.88  8.94 0.014
NLR 3.2940  1.88 4.17  2.23 0.045 3.8329  2.04 4.08  2.13 0.148
Platelets 298097.43  155960.56 301713.33  121897.14 0.898 27187.25  91602.90 283976.45  113343.38 <0.0001
PLR 0.127  0.06 0.1592  0.08 0.032 0.139  0.07 0.1543  0.1 0.034
Troponin I 5.01  13.97 4.45  11.42 0.828 6.12  14.04 6.54  14.11 0.712
WBC: white blood cell, NLR: neutrophil lymphocyte ratio, PLR: platelet lymphocyte ratio, SD: standard deviation.
Table 3 – The impact of gender on CVRFs, cardiac troponin I and inflammatory markers.
Variables Male
(with no risk factor)
n = 151
Male
(with risk factor)
n = 484
P value Female
(with no risk factor)
n = 88
Female
(with risk factor)
n = 236
P value
Total WBC 10986.36  3782.55 11644.93  6813.88 0.257 9300.11  2733.51 11926.50  10648.02 0.023
Neutrophil 72.32  9.94 72.29  10.11 0.975 67.34  11.21 71.89  10.12 0.001
Lymphocyte 21.98  11.15 21.80  9.07 0.841 29.75  34.14 22.01  8.76 0.001
NLR 4.074  2.021 4.1208  2.16 0.814 3.18  1.90 4.0287  2.11 0.001
Platelets 267493.05  82639.56 278569.07  111445.35 0.260 303088.64  131898.48 299575.55  118340.85 0.818
PLR 0.1416  0.07 0.1511  0.09 0.231 0.1306  0.07 0.1620  0.1 0.007
Troponin I 8.03  16.27 7.2832  14.93 0.600 2.36  7.74 4.50  11.35 0.104
WBC: white blood cell, NLR: neutrophil lymphocyte ratio, PLR: platelet lymphocyte ratio, SD: standard deviation.
i n d i a n h e a r t j o u r n a l 6 7 ( 2 0 1 5 ) 4 4 4 – 4 5 1448(p = 0.903) all other blood cells showed signiﬁcant association
withmortality. Expired patients had raised levels of total WBC
(15195.33  16232.93 vs 10972.65  5470.91; p < 0.0001), neu-
trophil (76.43  9.14 vs 71.22  10.23; p < 0.0001), NLR (5.14
 2.28 vs 3.87  2.05; p < 0.0001) and troponin I (12.83  19.9 vs
5.54  1 12.91; p < 0.0001) and lower lymphocyte counts (18.18
 8.26 vs 23.09  14.21; p = 0.01) as compared to live patients.
3.5. Correlation between various inﬂammatory markers,
troponin and mortality
Except for PLR, a highly signiﬁcant association was observed
between mortality and total WBC (p < 0.0001), neutrophil
(p < 0.0001), lymphocyte (p < 0.0001), platelet (p = 0.009) NLR
(p < 0.0001), and troponin I (p < 0.0001) (Table 6). Though
comparatively less strong, a signiﬁcant correlation was found
between CVRFs and WBC (p = 0.002), neutrophil (p = 0.047),
NLR ( p = 0.04) and troponin I (p = 0.046).
4. DiscussionIn the present study, 959 patients with evidence of unstable
angina, STEMI and NSTEMI, showed a strong relationship
between circulating leukocyte subtypes with modiﬁable risk
factors of CVD. The association was more speciﬁc in female
and older population.
Our study ﬁndings suggest that effect of WBC, neutrophil,
lymphocyte, NLR and PLR share strong relation with different
speciﬁc CVRFs. In particular, we observed that hypertension
has the strong relation with WBC, lymphocytes, and PLR,
diabetes has the positive relation with WBC, neutrophil,
lymphocytes, NLR and PLR, and smoking had speciﬁcassociation with WBC, NLR and PLR. Male gender with risk
factor have no speciﬁc relation with circulating blood
components and troponin I while the female gender with
risk factor have positive effect on WBC, neutrophil, lympho-
cyte, NLR, and PLR.
Atherosclerosis – a process causing narrowing and hard-
ening of the arteries involves active cellular and passive
inﬁltrative response to endothelial injury and is dominant
cause of CAD.12 The inﬂammatory response involves the
activation of leukocytes (white blood cells) and is mediated, in
part, by a family of cytokines and chemokines. The participa-
tion of immune competent cells producing pro-inﬂammatory
cytokines in atherosclerotic lesion is well documented
phenomena.13 Many of the coronary risk factors that predis-
pose a person to the development of atherosclerosis, such as
hypercholesterolemia, hypertension, smoking, diabetes, fam-
ily history of premature CAD and natural ageing are also
associated with endothelial dysfunction. These factors cause
endothelial injury and contribute to deleterious consequences
of atherosclerosis.6,14,15 The crucial role of leukocytes in the
inﬂammatory responses is undebatable. The severity and
extent of leukocyte facilitate pathogenicity of inﬂammation is
controllable and repairable in nature. However, in presence of
various CVRFs this tightly controlled microenvironment
becomes highly susceptible to changes.16
Cardiovascular disease (CVD) is a major cause of morbidity
and mortality in patients with diabetes. Prospective studies
have demonstrated that increased levels of pro-inﬂammatory
markers such as CRP or reduced levels of anti-inﬂammatory
markers such as adiponectin predict the development of Type
2 diabetes.17–20 Drugs exerting anti-inﬂammatory and vascular
effects have future potential to be used within an array of
interventions aimed at reducing the enormous cardiovascular
Table 5 – Association of various inflammatory markers and cardiac troponin I with mortality.
Variables Expired (n = 96) Survived (n = 863) P- value
Total WBC <0.0001
Mean  SD 15195.33  16232.93 10972.65  5470.91
Quartiles 25 8919.50 8400
50 12200 1020
75 17965 129990
Neutrophil <0.0001
Mean  SD 76.43  9.14 71.22  10.23
Quartiles 25 72.00 65.00
50 79.50 72.00
75 83.00 80.00
Lymphocyte 0.01
Mean  SD 18.18  8.26 23.09  14.21
Quartiles 25 12 16
50 15 21
75 22 28
NLR <0.001
Mean  SD 5.14  2.28 3.87  2.05
Quartiles 25 3.36 2.24
50 5.03 3.36
75 6.92 5.00
Platelet 0.006
Mean  SD 254537.81  113740.11 28749.11  111150.15
Quartiles 25 177000 215000
50 253450 273000
75 323800 348000
PLR 0.092
Mean  SD 0.16  0.09 0.14  0.08
Quartiles 25 0.086 0.088
50 0.152 0.129
75 0.213 0.193
Troponin I <0.001
Mean  SD 12.83  19.90 5.54  12.91
Quartiles 25 0.119 0.01
50 1.072 0.11
75 18.26 2.46
WBC: white blood cell, NLR: neutrophil lymphocyte ratio, PLR: platelet lymphocyte ratio, SD: standard deviation.
i n d i a n h e a r t j o u rn a l 6 7 ( 2 0 1 5 ) 4 4 4 – 4 5 1 449burden associated with Type 2 diabetes. There is some
evidence to suggest that this immune activation may precede
insulin resistance in diabetic and pre-diabetic states and
ultimatelymay be the factor that initially increases cardiovas-
cular risk in these disease processes.21 Zaidan et al showed
that elevation in leukocyte count especially neutrophils have
effect on the development of microalbuminuria – process
associatedwith both diabetes and hypertension.22 In onemore
study, chung et al disclosed the association of peripheral total
WBC, neutrophil counts with the advancement of diabetes
nephropathy.23 Increased values of NLR and PLR in diabetics
was reported by Akbas et al where possible contributors of this
association found were increased inﬂammation and endothe-
lial dysfunction in this population.24 Moreover, the leucocyte
counts were also appeared to be an independent predictor for
the severity of CAD in diabetes patients.25
Though, inﬂammatory processes are important partici-
pants in the pathophysiology of hypertension the putative
underline mechanism of inﬂammation in hypertension is
indistinct. One of the possibility is the hypertension induced
arterial wall damage causing endothelial dysfunction and pro-
inﬂammatory changes.12 Another mechanism could be the
contribution of IL-17 to the vascular physiology of hyperten-
sion facilitating vascular accumulation of leukocytes.26 Wehave observed signiﬁcant association of hypertension with
total WBC, lymphocytes and PLR. Tatsukawa et al concluded
that elevated WBC and neutrophil are associated with
hypertension among Japanese population.27 In accordance
to our study an elevated PLR in hypertensive patients was
reported earlier also.28
Though interaction between WBC count and smoking
status has been examined by few previous studies, their
results are inconsistent.29–31 Acute cigarette smoke has a
suppressive effect on the number of eosinophils and several
inﬂammatory cytokines, possibly due to the anti-inﬂammato-
ry effect of carbon monoxide.32 Our study also observed that
smoking has strong effect on WBC. Other studies found the
association between circulating speciﬁc leucocyte and smok-
ing and concluded that smoking is speciﬁcally related to
neutrophil and total WBC.33 In spite of earlier documentation
of a positive correlation between smoking and neutrophil
percentage, the effect of smoking on platelets and platelet
parameters are contradictory.34 One study from Thailand
showedno correlation betweenplatelets levels and smoking,35
another study indicted higher platelet counts in smokers,36
which is concomitant with our study results.
The gender difference in the association between leuko-
cytes and CVRFs could be attributed by many factors. The
Table 6 – Correlation between various inflammatory
markers and cardiac troponin I with mortality.
Risk factors Mortality
Total WBC Correlation Coefﬁcient 0.101a 0.140a
Sig. (2-tailed) 0.002 0.000
Neutrophil Correlation Coefﬁcient 0.064b 0.168a
Sig. (2-tailed) 0.047 0.000
Lymphocyte Correlation Coefﬁcient 0.063 0.166a
Sig. (2-tailed) 0.052 0.000
NLR Correlation Coefﬁcient 0.066b 0.168a
Sig. (2-tailed) 0.040 0.000
Platelet Correlation Coefﬁcient 0.019 0.085a
Sig. (2-tailed) 0.557 0.009
PLR Correlation Coefﬁcient 0.048 0.046
Sig. (2-tailed) 0.138 0.156
Troponin I Correlation Coefﬁcient 0.064b 0.175a
Sig. (2-tailed) 0.046 0.000
WBC: white blood cell, NLR: neutrophil lymphocyte ratio, PLR:
platelet lymphocyte ratio, SD: standard deviation.
a Correlation is signiﬁcant at the 0.01 level (2-tailed).
b Correlation is signiﬁcant at the 0.05 level (2-tailed).
i n d i a n h e a r t j o u r n a l 6 7 ( 2 0 1 5 ) 4 4 4 – 4 5 1450leukocytes tend to increase in presence of CVRFs, and hence
higher prevalence of risk factors denote greater degree of
correlation between risk factors and WBC subtypes in
females.27 Similar results were reported by Bovill et al, where
signiﬁcant relationship between mean WBC counts and
peripheral vascular disease was observed in females only.37
Likewise the age related relationship found in current study
could be explained by the fact that as the age advances the
prevalence of risk factors also increases.
Earlier reports have disclosed that elevated baseline WBC
count is a strong and independent predictor for adverse
cardiovascular events.38 Investigators of GRACE study exam-
ined the relationship between leukocyte count and hospital
events among patients presented with an ACS.39 In the same
line, our study group also showed strongly association of
mortality with circulating inﬂammatory markers.
5. ConclusionIn this study authors concluded thatWBC count and cell types
with its various ratiosmay aid as important prognosticmarker
in ACS patients with the CVRF.1. Hypertensive, diabetics, smokers have signiﬁcantly higher
levels of totalWBC counts and PLR irrespective of troponin I
elevation.2. Hypertensive patients having ACS had signiﬁcantly altered
total WBC, lymphocytes and PLR.3. In diabetes all blood cell types and ratios were signiﬁcantly
altered except platelet count and troponin I.4. Smokers have higher level of total WBC count and NLR.
5. The association of elevated total WBC, lymphocyte and PLR
with CVRFs are found more so in females and older
population.6. PLR ratio rises irrespective of age but elderly patients have
lower lymphocyte count and higher total WBC and platelet
count.Conﬂicts of interestThe authors have none to declare.
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